BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2009
View Archived Issues
Additive antitumor activity seen with oncolytic measles virus and bevacizumab in glioma model
Read More
Schering-Plough presents novel gamma-secretase modulators for Alzheimer's disease
Read More
Shionogi presents NPY Y5 receptor antagonists for the treatment of obesity
Read More
(R)-Gossypol is safe and well tolerated in glioblastoma and lymphoma patients in phase II trials
Read More
ASCO snapshots: Agents investigated in leukemia, myelodysplasia
Read More
MKC-1 shows limited activity in platinum-resistant ovarian cancer
Read More
Mixed results seen with depsipeptide in radioiodine-refractory thyroid cancer
Read More
Schering-Plough discloses kinesin spindle protein inhibitors for cancer treatment
Read More
Nerviano Medical Sciences claims Aurora B kinase inhibitors for the treatment of cancer
Read More
Abbott describes vanilloid TRPV1 receptor antagonists for the treatment of pain
Read More
Oral L-arginine or L-citrulline improves endothelial dysfunction in heart failure outpatients
Read More
EMEA provides information on possible interaction between clopidogrel and PPIs
Read More
Lundbeck and Takeda report mixed results from phase III trials of Lu AA-21004 in MDD
Read More
Centocor signs 5-year CRADA with NCI to develop novel cell therapies to treat cancer
Read More
Elite and Epic have announced initial closing under March 2009 strategic alliance agreement
Read More
Johnson & Johnson initiates cash tender offer to acquire Cougar Biotechnology
Read More
Progenics discontinues development for PRO-206 in hepatitis C
Read More
StemCells reports phase I results for HuCNS-SC cells in Batten disease
Read More
FDA accepts for review Dyax's complete response submission for DX-88 in HAE
Read More
Kuros completes recruitment in phase IIb Kur-111 trial in tibial plateau fractures
Read More
Active Biotech completes enrollment in phase II TASQ study
Read More
Metabasis receives development event payment from Roche for MB-11362
Read More
PanGenetics receives approval for phase I anti-NGF antibody trial in chronic pain
Read More
Sinovac commences production of influenza A vaccine
Read More
CSL and Talecris mutually agree to terminate August 2008 merger agreement
Read More
Alder and Schering-Plough expand collaborative alliance agreement in monoclonal antibodies
Read More